Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'HIRAOKA A' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 88 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hiraoka, A; Kojima, N; Yamauchi, Y; Ninomiya, T; Masumoto, T; Michitaka, K; Horiike, N; Onji, M
      An autopsy case of primary biliary cirrhosis with severe interstitial pneumonia

      INTERNAL MEDICINE
    2. Asou, N; Adachi, K; Tamura, J; Kanamaru, A; Kageyama, S; Hiraoka, A; Omoto, E; Akiyama, H; Tsubaki, K; Saito, K; Kuriyama, K; Oh, H; Kitano, K; Miyawaki, S; Takeyama, K; Yamada, O; Nishikawa, K; Takahashi, M; Matsuda, S; Ohtake, S; Ohno, R
      Analysis of prognostic factors in newly diagnosed patients with acute promyelocytic leukemia: the APL92 study of the Japan Adult Leukemia Study Group(JALSG)

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    3. Hiraoka, A; Ohashi, Y; Okamoto, S; Moriyama, Y; Nagao, T; Kodera, Y; Kanamaru, A; Dohy, H; Masaoka, T
      Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation

      BONE MARROW TRANSPLANTATION
    4. Hiraoka, A; Seiki, K; Oda, H; Eguchi, N; Urade, Y; Tominaga, I; Baba, K
      Charge microheterogeneity of the beta-trace proteins (lipocalin-type prostaglandin D synthase) in the cerebrospinal fluid of patients with neurological disorders analyzed by capillary isoelectrofocusing

      ELECTROPHORESIS
    5. Hagimoto, R; Koike, K; Sakashita, K; Ishida, T; Nakazawa, Y; Kurokawa, Y; Kamijo, T; Saito, S; Hiraoka, A; Kobayashi, M; Komiyama, A
      A possible role for maternal HLA antibody in a case of alloimmune neonatalneutropenia

      TRANSFUSION
    6. Iida, S; Hiraoka, A; Tai, T; Noritake, H
      Irregular resistance change in thin Ag film on Si substrate

      JAPANESE JOURNAL OF APPLIED PHYSICS PART 2-LETTERS
    7. Shinjo, K; Takeshita, A; Ohnishi, K; Sakura, T; Miyawaki, S; Hiraoka, A; Takeuchi, M; Tomoyasu, S; Wakita, H; Ata, K; Fukutani, H; Ueda, R; Ohno, R
      Good prognosis of patients with acute promyelocytic leukemia who achieved second complete remission (CR) with a new retinoid, AM80, after relapse from CR induced by all-trans-retinoic acid

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    8. Karasuno, T; Teshima, H; Hiraoka, A; Nakamura, H; Masaoka, T
      Successful bone marrow transplantation in an adult patient with reactive hemophagocytic syndrome associated with myelodysplastic syndrome

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    9. Fukuda, H; Teshima, H; Karasuno, T; Hiraoka, A; Nakamura, H; Masaoka, T
      Differences between lymphocyte subsets, after allogeneic bone marrow transplantation, in patients who received tacrolimus and patients who received cyclosporin (vol 71, pg 70, 2000)

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    10. Fukuda, H; Teshima, H; Karasuno, T; Hiraoka, A; Nakamura, H; Masaoka, T
      Differences between lymphocyte subsets, after allogeneic bone marrow transplantation, in patients who received tacrolimus and patients who received cyclosporin A

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    11. Masaoka, T; Hiraoka, A; Okamoto, S; Kodera, Y; Cao, LX; Lu, DP; Chen, YC; Chen, PM; Kim, DJ; Chiu, E; Liang, R; Teh, A
      Asian Pacific cooperative study of allogeneic bone marrow transplantation (vol 70, 190, 1999)

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    12. Uoshima, N; Karasuno, T; Yagi, T; Kawamoto, S; Hasegawa, T; Yasumi, M; Murakami, M; Teshima, H; Nakamura, H; Hiraoka, A; Masaoka, T
      Late onset cyclosporine-induced cerebral blindness with abnormal SPECT imagings in a patient undergoing unrelated bone marrow transplantation

      BONE MARROW TRANSPLANTATION
    13. Yagi, T; Karasuno, T; Hasegawa, T; Yasumi, M; Kawamoto, S; Murakami, M; Uosima, N; Nakamura, H; Hiraoka, A; Masaoka, T
      Acute abdomen without cutaneous signs of varicella zoster virus infection as a late complication of allogeneic bone marrow transplantation: importance of empiric therapy with acyclovir

      BONE MARROW TRANSPLANTATION
    14. Nakamura, H; Komatsu, K; Ayaki, M; Kawamoto, S; Murakami, M; Uoshima, N; Yagi, T; Hasegawa, T; Yasumi, M; Karasuno, T; Teshima, H; Hiraoka, A; Masaoka, T
      Serum levels of soluble IL-2 receptor, IL-12, IL-18, and IFN-gamma in patients with acute graft-versus-best disease after allogeneic bone marrow transplantation

      JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    15. Hiraoka, A; Tominaga, I; Hori, K
      Sodium dodecylsulfate capillary gel electrophoretic measurement of the concentration ratios of albumin and alpha(2)-macroglobulin in cerebrospinal fluid and serum of patients with neurological disorders

      JOURNAL OF CHROMATOGRAPHY A
    16. Yoshida, M; Tsubaki, K; Kobayashi, T; Tanimoto, M; Kuriyama, K; Murakami, H; Minami, S; Hiraoka, A; Takahashi, I; Naoe, T; Asou, N; Kageyama, S; Tomonaga, M; Saito, H; Ohno, R
      Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    17. Masaoka, T; Hiraoka, A; Okamoto, S; Kodera, Y; Cao, LX; Lu, DP; Chen, YC; Chen, PM; Kim, DJ; Chiu, E; Liang, R; Teh, A
      Asian Pacific cooperative study of allogeneic bone marrow transplantation

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    18. Miyawaki, S; Tanimoto, M; Kobayashi, T; Minami, S; Tamura, J; Omoto, E; Kuriyama, K; Hatake, K; Saito, K; Kanamaru, A; Oh, H; Ohtake, S; Asou, N; Sakamaki, H; Yamada, O; Jinnai, I; Tsubaki, K; Takeyama, K; Hiraoka, A; Matsuda, S; Takahashi, M; Shimazaki, C; Adachi, K; Kageyama, S; Sakura, T; Ohno, R
      No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    19. Miyawaki, S; Kobayashi, T; Tanimoto, M; Kuriyama, K; Murakami, H; Yoshida, M; Minami, S; Minato, K; Tsubaki, K; Omoto, E; Oh, H; Jinnai, I; Sakamaki, H; Hiraoka, A; Kanamura, A; Takahashi, I; Saito, K; Naoe, T; Yamada, O; Asou, N; Kageyama, S; Emi, N; Ueda, T; Tomonaga, M; Saito, H; Ueda, R; Ohno, R
      Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    20. Hirao, H; Muraoka, Y; Yamada, T; Hiraoka, A; Nakano, Y; Sasaki, S; Teragawa, H; Kato, M; Yamagata, T; Matsuura, H; Kajiyama, G
      Idiopathic verapamil-sensitive left ventricular tachycardia complicated byright ventricular outflow tract ventricular tachycardia and ventricular fibrillation

      INTERNAL MEDICINE
    21. Kodera, Y; Morishima, Y; Kato, S; Akiyama, Y; Sao, H; Matsuyama, T; Kawa, K; Sakamaki, H; Nakagawa, S; Hirabayashi, N; Dohi, H; Okamoto, S; Hiraoka, A; Gondo, H; Tsuchida, M; O, H; Harada, M; Asano, S; Juji, T; Sasazuki, T; Takaku, F
      Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia

      BONE MARROW TRANSPLANTATION
    22. Oh, H; Takahashi, S; Sakamaki, S; Kato, S; Okamoto, S; Hiraoka, A; Kasai, M; Maseki, N; Dohy, H; Kodera, Y
      Hepatic veno-occlusive disease after stem cell transplantation in Japan

      BONE MARROW TRANSPLANTATION
    23. Nakamura, H; Nakao, T; Ujiie, H; Karasuno, T; Teshima, H; Komatsu, K; Ishiguro, S; Hiraoka, A; Masaoka, T
      Induction of autologous graft-versus-host disease after autologous peripheral blood stem cell transplantation

      JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    24. UEDA T; MIYAWAKI S; ASOU N; KURAISHI Y; HIRAOKA A; KURIYAMA K; MINAMI S; OHSHIMA T; INO T; TAMURA J; KANAMARU A; NISHIKAWA K; TANIMOTO M; OH H; SAITO K; NAGATA K; NAOE T; YAMADA O; URASAKI Y; SAKURA T; OHNO R
      RESPONSE-ORIENTED INDIVIDUALIZED INDUCTION THERAPY WITH 6 DRUGS FOLLOWED BY 4 COURSES OF INTENSIVE CONSOLIDATION, 1 YEAR MAINTENANCE AND INTENSIFICATION THERAPY - THE ALL90 STUDY OF THE JAPAN ADULT LEUKEMIA STUDY-GROUP

      International journal of hematology
    25. KAWAMURA S; UEDA R; OHNO R; MASAOKA T; HIRAOKA A; DOHY H; KYO T; TOYAMA K; KIMURA Y; SASAKI T; TAKAMI H; TSUBAKI K; MIZOGUCHI H; HAMAJIMA N
      PREGNANCY AMONG LONG-TERM SURVIVORS OF ACUTE-LEUKEMIA - A SECOND NATIONWIDE SURVEY

      International journal of hematology
    26. Tanimoto, M; Miyawaki, S; Ino, T; Kyo, T; Sakamaki, H; Naoe, T; Hiraoka, A; Asou, N; Ohshima, T; Tsubaki, K; Kuriyama, K; Ueda, T; Minamil, S; Okabe, K; Saito, H; Murakami, H; Hirano, M; Dohy, H; Onozawa, Y; Suzuki, H; Ohno, R
      Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult patients with acute lymphoblastic leukemia: The ALL-87 Study of the Japan Adult Leukemia Study Group (JALSG)

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    27. TERAGAWA H; HIRAO H; MURAOKA Y; HIRAOKA A; YAMADA T; KATO M; YAMAGATA T; MATSUURA H; KAJIYAMA G
      ISCHEMIC AREAS BE DETECTED BY ADENOSINE TRIPHOSPHATE-INDUCED CHANGES OF THE QT INTERVALS

      Journal of the American College of Cardiology
    28. HIROTA K; MONGUCHI Y; SAJIKI H; YATOME C; HIRAOKA A; KITADE Y
      A CONVENIENT SYNTHESIS OF ACYCLIC ADENOSINES WITH AN UNSATURATED SIDE-CHAIN BY MODIFICATION OF 9-(2,3-O-ISOPROPYLIDENE-D-RIBITYL)ADENINE

      Nucleosides & nucleotides
    29. ASOU N; ADACHI K; TAMURA J; KANAMARU A; KAGEYAMA S; HIRAOKA A; OMOTO E; AKIYAMA H; TSUBAKI K; SAITO K; KURIYAMA K; OH H; KITANO K; MIYAWAKI S; TAKEYAMA K; YAMADA O; NISHIKAWA K; TAKAHASHI M; MATSUDA S; OHTAKE S; SUZUSHIMA H; EMI N; OHNO R
      ANALYSIS OF PROGNOSTIC FACTORS IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTICLEUKEMIA TREATED WITH ALL-TRANS-RETINOIC ACID AND CHEMOTHERAPY

      Journal of clinical oncology
    30. WAKASUGI S; TESHIMA H; NAKAMURA H; HASHIZUME T; MAEDA T; HIRAOKA A; HASEGAWA Y; MASAOKA T
      TC-99M MIBI LOCALIZATION IN BONE-MARROW - A MARKER OF BONE-MARROW MALIGNANCY

      Clinical nuclear medicine
    31. KONDOH K; KOSHIBA T; HIRAOKA A; SATO M
      GAMMA-IRRADIATION DAMAGE TO THE TONOPLAST IN CULTURED SPINACH CELLS

      Environmental and experimental botany
    32. MARUYA E; SAJI H; SEKI S; FUJII Y; KATO K; KAI S; HIRAOKA A; KAWA K; HOSHI Y; ITO K; YOKOYAMA S; JUJI T
      EVIDENCE THAT CD31, CD49B, AND CD62L ARE IMMUNODOMINANT MINOR HISTOCOMPATIBILITY ANTIGENS IN HLA IDENTICAL SIBLING BONE-MARROW TRANSPLANTS

      Blood
    33. MIO H; KAGAMI N; YOKOKAWA S; KAWAI H; NAKAGAWA S; TAKEUCHI K; SEKINE S; HIRAOKA A
      ISOLATION AND CHARACTERIZATION OF A CDNA FOR HUMAN, MOUSE, AND RAT FULL-LENGTH STEM-CELL GROWTH-FACTOR, A NEW MEMBER OF C-TYPE LECTIN SUPERFAMILY

      Biochemical and biophysical research communications (Print)
    34. Hiraoka, A; Nagasawa, T; Ohta, N; Sugimura, A; Shimizu, N; Ooi, K; Shimizu, S
      A human myeloid cell line producing stem cell growth factor, KPB-M15, secretes another growth factor active on murine hematopoietic progenitor cells

      ACTA HAEMATOLOGICA
    35. HIRAOKA A; ARATO T; TOMINAGA I; EGUCHI N; ODA H; URADE Y
      SODIUM DODECYL SULFATE-CAPILLARY GEL-ELECTROPHORETIC ANALYSIS OF MOLECULAR-MASS MICROHETEROGENEITY OF BETA-TRACE PROTEIN IN CEREBROSPINAL-FLUID FROM PATIENTS WITH CENTRAL-NERVOUS-SYSTEM DISEASES

      Journal of chromatography
    36. HIRAOKA A; ARATO T; TOMINAGA I; EGUCHI N; ODA H; URADE Y
      ANALYSIS OF LOW-MOLECULAR-MASS PROTEINS IN CEREBROSPINAL-FLUID BY SODIUM DODECYL-SULFATE CAPILLARY GEL-ELECTROPHORESIS

      Journal of chromatography B. Biomedical sciences and applications
    37. YUASA H; HAMAJIMA N; UEDA R; OHNO R; ASOU N; UTSUNOMIYA A; OGURA M; TAKIGAWA N; UEDA T; HIRAOKA A; MATSUDA S; KURAISHI Y; NISHIKAWA K; UIKE N; TAKESHITA A; TAKEMOTO Y; SHIMAZAKI C; SAKAMAKI H; INO T; MATSUSHIMA T; KURIYAMA K; HIRAI H; NAOE T; TSUBAKI K; TAKAHASHI M; TAKEYAMA K; MORISHIMA Y; ITOH K; OMOTO E; HODOHARA K; TAKAHASHI I
      CASE-CONTROL STUDY OF LEUKEMIA AND DIAGNOSTIC RADIATION EXPOSURE

      International journal of hematology
    38. HIRAOKA A; ARATO T; TOMINAGA I
      REDUCTION IN BLOOD-FREE CARNITINE LEVELS IN ASSOCIATION WITH CHANGES IN SODIUM VALPROATE (VPA) DISPOSITION IN EPILEPTIC PATIENTS TREATED WITH VPA AND OTHER ANTIEPILEPTIC DRUGS

      Biological & pharmaceutical bulletin
    39. BESSHO M; HIRASHIMA K; ASANO S; IKEDA Y; OGAWA N; TOMONAGA M; TOYAMA K; NAKAHATA T; NOMURA T; MIZOGUCHI H; YOSHIDA Y; NIITSU Y; KOHGO Y; MIYAZAKI T; TAKAMI H; MIURA AB; SASAKI H; ABE K; KURIYA S; SHIGA Y; SHIBATA A; HAYASHI N; MURAKAMI H; MIYAWAKI S; ENOKIHARA H; TAKEMURA Y; MIURA Y; TAKAGI S; TOYA K; KOBAYASHI I; KOMIYAMA A; MITSUHASHI S; MOTOYOSHI K; SAKURAI M; OHTA M; YOSHIDA S; HIGASHIHARA M; HIRAI H; MORI M; MUTO Y; HIROSAWA S; HIROSE S; OHSHIMA T; TSURUOKA N; OMINE M; TSUKIMOTO I; ONOZAWA Y; AOKI I; TSUNEMATSU Y; KAWATO M; YABE H; KITAHARA M; MATSUYAMA S; AKATSUKA N; HIRASAWA A; AOYAGI Y; NISHIHIRA H; HIRANO M; HOTTA T; KODERA Y; KOJIMA S; MINAMI N; OHTAKA S; TAKIGUCHI T; NAKAMURA T; FUJIYAMA Y; SUZUKI T; AKIYAMA Y; NAKAGAWA M; MISAWA S; HIBI S; FUJII H; MATSUZAWA Y; KISHIMOTO T; KITANI T; OHSAWA N; TATSUMI N; KISHIDA T; HIRAOKA A; KAWA K; NII M; KONISHI S; FUKUHARA S; HORIUCHI A; KAKISHITA E; MATSUI T; ISHIKAWA T; OMOTO E; YAWATA Y; KOBAYASHI M; KURAMOTO A; DOHY H; KANEKO T; SHINOHARA K; TAGUCHI H; UCHIDA T; TANAKA T; KOSAKA M; NIHO Y; UEDA K; ETO S; MIYAZAKI S; AMENOMORI M; KAWAKITA M; NISHIMURA H; UIKE N; NATORI H; IKEDA S; TAMURA K
      TREATMENT OF THE ANEMIA OF APLASTIC-ANEMIA PATIENTS WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN IN COMBINATION WITH GRANULOCYTE-COLONY-STIMULATING FACTOR - A MULTICENTER RANDOMIZED CONTROLLED-STUDY

      European journal of haematology
    40. HIRAOKA A; ARATO T; TOMINAGA I; ANJYO A
      CAPILLARY ELECTROPHORETIC ANALYSES OF BETA-TRACE PROTEIN AND OTHER LOW-MOLECULAR-WEIGHT PROTEINS IN CEREBROSPINAL-FLUID FROM PATIENTS WITH CENTRAL-NERVOUS-SYSTEM DISEASES

      Journal of pharmaceutical and biomedical analysis
    41. ASOU N; ADACHI K; TAMURA J; KANAMARU A; KAGEYAMA S; HIRAOKA A; OMOTO E; SAKAMAKI H; TSUBAKI K; SAITO K; OHNO R
      ALL-TRANS-RETINOIC ACID THERAPY FOR NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA - COMPARISON WITH INTENSIVE CHEMOTHERAPY

      Cancer chemotherapy and pharmacology
    42. KAWAKAMI M; UEDA S; MAEDA T; KARASUNO T; TESHIMA H; HIRAOKA A; NAKAMURA H; TANAKA K; MASAOKA T
      VIDARABINE THERAPY FOR VIRUS-ASSOCIATED CYSTITIS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Bone marrow transplantation
    43. HARA T; MATSUMOTO M; TSUJI S; NAGASAWA S; HIRAOKA A; MASAOKA T; KODAMA K; HORAI T; SAKUMA T; SEYA T
      HOMOLOGOUS COMPLEMENT ACTIVATION ON DRUG-INDUCED APOPTOTIC CELLS FROMA HUMAN LUNG ADENOCARCINOMA CELL-LINE

      Immunobiology
    44. HIYOSHI M; TAGAWA S; TAKUBO T; TANAKA K; NAKAO T; HIGENO Y; TAMURA K; SHIMAOKA M; FUJII A; HIGASHIHATA M; YASUI Y; KIM T; HIRAOKA A; TATSUMI N
      EVALUATION OF THE AMPLICOR CMV TEST FOR DIRECT-DETECTION OF CYTOMEGALOVIRUS IN PLASMA SPECIMENS

      Journal of clinical microbiology
    45. HIRAOKA A; KAWAKAMI M; FUKUDA H; NAKAMURA H; KARASUNO T; TESHIMA H; MASAOKA T
      SIMPLE DIAGNOSIS OF GRAFT-VERSUS-HOST DISEASE

      Journal of allergy and clinical immunology
    46. HIRAOKA A; SUGIMURA A; SEKI T; NAGASAWA T; OHTA N; SHIMONISHI M; HAGIYA M; SHIMIZU S
      CLONING, EXPRESSION, AND CHARACTERIZATION OF A CDNA-ENCODING A NOVEL HUMAN GROWTH-FACTOR FOR PRIMITIVE HEMATOPOIETIC PROGENITOR CELLS

      Proceedings of the National Academy of Sciences of the United Statesof America
    47. TOBITA T; TAKESHITA A; KITAMURA K; OHNISHI K; YANAGI M; HIRAOKA A; KARASUNO T; TAKEUCHI M; MIYAWAKI S; UEDA R; NAOE T; OHNO R
      TREATMENT WITH A NEW SYNTHETIC RETINOID, AM80, OF ACUTE PROMYELOCYTICLEUKEMIA RELAPSED FROM COMPLETE REMISSION INDUCED BY ALL-TRANS-RETINOIC ACID

      Blood
    48. HIRAOKA A
      RESULTS OF A PHASE-III STUDY ON PROPHYLACTIC USE OF FK506 FOR ACUTE GVHD COMPARED WITH CYCLOSPORINE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Blood
    49. YANO F; HIRAOKA A; ITOGA T; MATSUBARA A; KOJIMA H; KANEHORI K; MITSUI Y
      X-RAY PHOTOELECTRON-SPECTROSCOPY STUDY ON NATIVE OXIDATION OF AS-IMPLANTED SI (100)

      Journal of vacuum science & technology. B, Microelectronics and nanometer structures processing, measurement and phenomena
    50. SHIODE N; KATO M; HIRAOKA A
      IMPAIRED ENDOTHELIUM-DEPENDENT VASODILATION OF CORONARY RESISTANCE VESSELS IN HYPERCHOLESTEROLEMIC PATIENTS

      Internal medicine
    51. HASEGAWA T; USHIRODA Y; KAWAGUCHI M; KITAZAWA Y; NISHIYAMA M; HIRAOKA A; NISHIJO J
      UV ABSORPTION SPECTROSCOPIC ANALYSIS OF THE MOLECULAR-ORIENTATION OF A DRUG PENETRATED INTO A DPPC MEMBRANE

      Langmuir
    52. KOBAYASHI T; MIYAWAKI S; TANIMOTO M; KURIYAMA K; MURAKAMI H; YOSHIDA M; MINAMI S; MINATO K; TSUBAKI K; OHMOTO E; OH H; JINNAI I; SAKAMAKI H; HIRAOKA A; KANAMARU A; TAKAHASHI I; SAITO K; NAOE T; YAMADA O; ASOU N; KAGEYAMA S; EMI N; MATSUOKA A; TOMONAGA M; SAITO H; UEDA R; OHNO R
      RANDOMIZED TRIALS BETWEEN BEHENOYL CYTARABINE AND CYTARABINE IN COMBINATION INDUCTION AND CONSOLIDATION THERAPY, AND WITH OR WITHOUT UBENIMEX AFTER MAINTENANCE INTENSIFICATION THERAPY IN ADULT ACUTE MYELOID-LEUKEMIA

      Journal of clinical oncology
    53. HIRAOKA A; MASAOKA T; SHIBATA H; OHNO R; KATOH S; HARADA M; MOTOYOSHI K; TAKAKU F; SAKUMA A
      5-YEAR FOLLOW-UP OF DOUBLE-BLIND TEST FOR ALLOGENEIC AND SYNGENEIC BONE-MARROW TRANSPLANTATION - EFFECTIVENESS OF HUMAN URINARY M-CSF FOR DISEASE-FREE SURVIVAL AFTER BMT

      Experimental hematology
    54. YANO F; HIRAOKA A; ITOGA T; KOJIMA H; KANEHORI K; MITSUI Y
      INFLUENCE OF ION-IMPLANTATION ON NATIVE OXIDATION OF SI IN A CLEAN-ROOM ATMOSPHERE

      Applied surface science
    55. HIRAOKA A
      DETECTION BY CAPILLARY ELECTROPHORESIS OF CHANGES IN THE BETA-TRACE PROTEIN-LEVELS IN CEREBROSPINAL-FLUID FROM PATIENTS WITH CENTRAL-NERVOUS-SYSTEM DISEASES

      Prostaglandins
    56. INOUE K; OGAWA H; YAMAGAMI T; SOMA T; TANI Y; TATEKAWA T; OJI Y; TAMAKI H; KYO T; DOHY H; HIRAOKA A; MASAOKA T; KISHIMOTO T; SUGIYAMA H
      LONG-TERM FOLLOW-UP OF MINIMAL RESIDUAL DISEASE IN LEUKEMIA PATIENTS BY MONITORING WT1 (WILMS-TUMOR GENE) EXPRESSION LEVELS

      Blood
    57. NAKAMURA H; TAGAWA S; SHIBANO S; KATASUNO T; TESHIMA H; HIRAOKA A; TATSUMI N; MASAOKA T
      SERUM LEVELS OF SOLUBLE TL-2 RECEPTOR, INTERFERON-1 AND IL-12 AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Blood
    58. OHNO R; ASOU N; KANAMARU A; ADACHI K; MIYAWAKI S; KAGEYAMA S; HIRAOKA A; OHMOTO E; SAKAMAKI H; TSUBAKI K; SAITO K; KURIYAMA K; OH H; KITANO Y
      JALSG-AML92 FOR NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) WITH ALL-TRANS-RETINOIC ACID (ATRA) FOLLOWED BY INTENSIVE CONSOLIDATION ACID MAINTENANCE INTENSIFICATION CHEMOTHERAPY - PROGNOSTIC FACTORS FORREMISSION AND SURVIVAL/

      Blood
    59. HIRAOKA A; HASEGAWA H; HORIUCHI A; MASAOKA T; OKUMA M; UCHINO H; NAGAI K
      COMBINATION EFFECT OF FOSFOMYCIN AND SULBACTAM CEFOPERAZONE FOR OPPORTUNISTIC INFECTIONS IN PATIENTS WITH HEMATOLOGICAL DISORDERS - A RANDOMIZED CROSS-OVER TRIAL OF SEQUENTIAL ADMINISTRATION/

      Blood
    60. YANO F; HIRAOKA A; ITOGA T; KOJIMA H; KANEHORI K; MITSUI Y
      X-RAY PHOTOELECTRON-SPECTROSCOPY STUDY OF SUBMONOLAYER NATIVE OXIDES ON HF-TREATED SI SURFACES

      Journal of vacuum science & technology. A. Vacuum, surfaces, and films
    61. MASAOKA T; HIRAOKA A; KANAMARU A; DOHY H; KODERA Y; MORIYAMA Y; OKAMOTO S
      FK506 THERAPY FOR PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTERALLOGENIC BONE-MARROW TRANSPLANTATION

      Experimental hematology
    62. KANAMARU A; TAKEMOTO Y; KAKISHITA E; DOHY H; KODERA Y; MORIYAMA Y; SHIBATA A; KASAI M; KATOH S; SAITOH H; MATSUDA T; HATTORI M; OKAMOTO S; ASANO S; HORIUCHI A; HARADA M; HIRAOKA A; MASAOKA T
      FK506 TREATMENT OF GRAFT-VERSUS-HOST DISEASE DEVELOPING OR EXACERBATING DURING PROPHYLAXIS AND THERAPY WITH CYCLOSPORINE AND OR OTHER IMMUNOSUPPRESSANTS/

      Bone marrow transplantation
    63. SATO M; YOKOYAMA S; KOSHIBA T; WATANABE M; HIRAOKA A
      GAMMA-IRRADIATION DAMAGE TO LEAF VACUOLE MEMBRANES OF CHELIDONIUM-MAJUS

      Environmental and experimental botany
    64. YANO Y; HIRAOKA A; OGUMA T
      ENHANCEMENT OF TOBRAMYCIN BINDING TO RAT RENAL BRUSH-BORDER MEMBRANE BY VANCOMYCIN

      The Journal of pharmacology and experimental therapeutics
    65. HIRAOKA A; KARAKAWA S; MURAOKA Y; FUJIWARA H; YAMAGATA T; MATSUURA H
      THE STRUCTURAL CHARACTERISTIC OF CORONARY SINUS IN PATIENTS WITH ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA (AVNRT)

      Circulation
    66. KANAMARU A; TAKEMOTO Y; TANIMOTO M; MURAKAMI H; ASOU N; KOBAYASHI T; KURIYAMA K; OHMOTO E; SAKAMAKI H; TSUBAKI K; HIRAOKA A; YAMADA O; OH H; SAITO K; MATSUDA S; MINATO K; UEDA T; OHNO R
      ALL-TRANS-RETINOIC ACID FOR THE TREATMENT OF NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA

      Blood
    67. HIRAOKA A; MIURA I; HATTORI M; TOMINAGA I; KUSHIDA K; MAEDA M
      PROTON MAGNETIC-RESONANCE SPECTROSCOPY OF CEREBROSPINAL-FLUID AS AN AID IN NEUROLOGICAL DIAGNOSIS

      Biological & pharmaceutical bulletin
    68. OHNO R; OHNISHI K; TAKESHITA A; TANIMOTO M; MURAKAMI H; KANAMARU A; ASOU N; KOBAYASHI T; KURIYAMA K; OHMOTO E; SAKAMAKI H; TSUBAKI K; HIRAOKA A; YAMADA O; OH H; FURUSAWA S; MATSUDA S; NAOE T
      ALL-TRANS-RETINOIC ACID THERAPY IN RELAPSED REFRACTORY OR NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) IN JAPAN

      Leukemia
    69. HIRAOKA A; MASAOKA T; MIZOGUCHI H; ASANO S; KODERA Y; KITAMURA K; TAKAKU F; KOMEMUSHI S
      RECOMBINANT HUMAN NONGLYCOSYLATED GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN ALLOGENEIC BONE-MARROW TRANSPLANTATION - DOUBLE-BLINDPLACEBO-CONTROLLED PHASE-III CLINICAL-TRIAL

      Japanese Journal of Clinical Oncology
    70. FUKUDA H; NAKAMURA H; TOMINAGA N; TESHIMA H; HIRAOKA A; SHIBATA H; MASAOKA T
      MARKED INCREASE OF CD8(-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION()S6F1(+) AND DC8(+)CD57(+) CELLS IN PATIENTS WITH GRAFT)

      Bone marrow transplantation
    71. YOKOTA T; TSUBOI A; OKAJIMA Y; OJI Y; MORIYAMA Y; TATEKAWA T; KARASUNO T; TOMINANGA N; TEJIMA H; HIRAOKA A; NAKAMURA H; MASAOKA T
      TREATMENT OF GRAFT FAILURE AFTER BONE-MARROW TRANSPLANTATION

      Leukemia research
    72. SATO M; HIRAOKA A
      REDUCTION OF GRAMINE CONCENTRATION BY GAMMA-IRRADIATION IN SEEDLINGS OF HORDEUM-VULGARE VAR AMAGINIJO

      Phytochemistry
    73. KURIYAMA K; TOMONAGA M; MATSUO T; KOBAYASHI T; MIWA H; SHIRAKAWA S; TANIMOTO M; ADACHI K; EMI N; HIRAOKA A; TOMINAGA N; IMAI K; ASOU N; TSUBAKI K; TAKAHASHI I; MINAMI S; YOSHIDA M; MURAKAMI H; MINATO K; OSHIMA T; FURUSAWA S; OHNO R
      POOR RESPONSE TO INTENSIVE CHEMOTHERAPY IN DE-NOVO ACUTE MYELOID-LEUKEMIA WITH TRILINEAGE MYELODYSPLASIA

      British Journal of Haematology
    74. INOUE K; SUGIYAMA H; OGAWA H; NAKAGAWA M; YAMAGAMI T; MIWA H; KITA K; HIRAOKA A; MASAOKA T; NASU K; KYO T; DOHY H; NAKAUCHI H; ISHIDATE T; AKIYAMA T; KISHIMOTO T
      WT1 AS A NEW PROGNOSTIC FACTOR AND A NEW MARKER FOR THE DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE-LEUKEMIA

      Blood
    75. INOUE K; SUGIYAMA H; OGAWA H; NAKAGAWA M; YAMAGAMI T; MIWA H; KITA K; HIRAOKA A; MASAOKA T; NASU K; KYO T; DOHY H; NAKAUCHI H; ISHIDATE T; AKIYAMA T; KISHIMOTO T
      WT1 AS A NEW PROGNOSTIC FACTOR AND A NEW MARKER FOR THE DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE-LEUKEMIA

      Blood
    76. INOUE K; SUGIYAMA H; OGAWA H; YAMAGAMI T; AZUMA T; OKA Y; MIWA H; KITA K; HIRAOKA A; MASAOKA T; NASU K; KYO T; DOHY H; HARA J; KANAMARU A; KISHIMOTO T
      EXPRESSION OF THE INTERLEUKIN-6 (IL-6), IL-6 RECEPTOR, AND GP130 GENES IN ACUTE-LEUKEMIA

      Blood
    77. KOBAYASHI T; MIYAWAKI S; TANIMOTO M; KURIYAMA K; MURAKAMI H; YOSHIDA M; KODERA Y; MINATO K; TSUBAKI K; OHMOTO E; OH H; JINNAI I; SAKAMAKI H; HIRAOKA A; KANAMARU A; TAKAHASHI I; FURUSAWA S; NAOE T; YAMADA O; ASOU N; NISHIKAWA K; OKABE K; OGURA M; TANAKA M; OHNO R
      RANDOMIZED TRIAL BETWEEN BEHENOYL CYTARABINE (BHAC) OR CYTARABINE IN COMBINATION CHEMOTHERAPY OF ADULT ACUTE MYELOID-LEUKEMIA (AML) (JALSG-AML89 PROTOCOL) AND ANALYSIS OF PROGNOSTIC FACTORS

      Blood
    78. HIRAOKA A; FUKUDA H; NAKAMURA H; KARASUNO T; TESHIMA H; SHIBATA H; HIRATA N; MASAOKA T
      CHANGE OF SUBSETS IN CD8-VERSUS-HOST DISEASE - AFTER ALLOGENEIC AND AUTOLOGOUS BONE-MARROW TRANSPLANTATIONS AND DURING POSTTRANSFUSION GRAFT-VERSUS-HOST DISEASE( LYMPHOCYTE ALONG WITH GRAFT)

      Blood
    79. OHNO R; NAOE T; KANAMARU A; YOSHIDA M; HIRAOKA A; KOBAYASHI T; UEDA T; MINAMI S; MORISHIMA Y; SAITO Y; FURUSAWA S; IMAI K; TAKEMOTO Y; MIURA Y; TESHIMA H; HAMAJIMA N
      A DOUBLE-BLIND CONTROLLED-STUDY OF GRANULOCYTE-COLONY-STIMULATING FACTOR STARTED 2 DAYS BEFORE INDUCTION CHEMOTHERAPY IN REFRACTORY ACUTE MYELOID-LEUKEMIA

      Blood
    80. HIRAOKA A; AKAI J; TOMINAGA I; HATTORI M; SASAKI H; ARATO T
      CAPILLARY ZONE ELECTROPHORETIC DETERMINATION OF ORGANIC-ACIDS IN CEREBROSPINAL-FLUID FROM PATIENTS WITH CENTRAL-NERVOUS-SYSTEM DISEASES

      Journal of chromatography
    81. HIRAOKA A; MIURA I; HATTORI M; TOMINAGA I; MACHIDA S
      CAPILLARY-ZONE ELECTROPHORETIC ANALYSES OF THE PROTEINS AND AMINO-ACID COMPONENTS IN CEREBROSPINAL-FLUID OF CENTRAL-NERVOUS-SYSTEM DISEASES

      Biological & pharmaceutical bulletin
    82. OHNO R; YOSHIDA H; FUKUTANI H; NAOE T; OHSHIMA T; KYO T; ENDOH N; FUJIMOTO T; KOBAYASHI T; HIRAOKA A; MIZOGUCHI H; KODERA Y; SUZUKI H; HIRANO M; AKIYAMA H; AOKI N; SHINDO H; YOKOMAKU S
      MULTIINSTITUTIONAL STUDY OF ALL-TRANS-RETINOIC ACID AS A DIFFERENTIATION THERAPY OF REFRACTORY ACUTE PROMYELOCYTIC LEUKEMIA

      Leukemia
    83. MASAOKA T; HIRAOKA A; KAKISHITA E; KANAMARU A; DOHY H
      PROPHYLACTIC ADMINISTRATION OF FK506 FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Experimental hematology
    84. KANAMARU A; HIRAOKA A; DOHY H; KODERA Y; MORIYAMA Y; OKAMOTO S; MASAOKA T
      FK506 FOR THE TREATMENT OF GRAFT-VERSUS-HOST DISEASE IN PATIENTS WHO RECEIVED CYCLOSPORINE AS THE PROPHYLAXIS OR THERAPY

      Experimental hematology
    85. MASAOKA T; HIRAOKA A; TESHIMA H; TOMINAGA N
      VARICELLA-ZOSTER VIRUS-INFECTION IN IMMUNOCOMPROMISED PATIENTS

      Journal of medical virology
    86. SATO M; HIRAOKA A; WATANABE M
      INHIBITION OF GAMMA-IRRADIATION-INDUCED OXIDATION OF CHLOROGENATE BY 1,3-DICAFFEOYLQUINATE IN XANTHIUM-OCCIDENTALE

      Phytochemistry
    87. OHNO R; KOBAYASHI T; TANIMOTO M; HIRAOKA A; IMAI K; ASOU N; TOMONAGA M; TSUBAKI K; TAKAHASHI I; KODERA Y; YOSHIDA M; MURAKAMI H; NAOE T; SHIMOYAMA M; TSUKADA T; TAKEO T; TESHIMA H; ONOZAWA Y; FUJIMOTO K; KURIYAMA K; HORIUCHI A; KIMURA I; MINAMI S; MIURA Y; KAGEYAMA S; TAHARA T; MASAOKA T; SHIRAKAWA S; SAITO H
      RANDOMIZED STUDY OF INDIVIDUALIZED INDUCTION THERAPY WITH OR WITHOUT VINCRISTINE, AND OF MAINTENANCE INTENSIFICATION THERAPY BETWEEN 4 OR 12 COURSES IN ADULT ACUTE MYELOID-LEUKEMIA - AML-87 STUDY OF THE JAPAN ADULT LEUKEMIA STUDY-GROUP

      Cancer
    88. HIRAOKA A; TOMINAGA N; TESHIMA H; NAKAMURA H; MASAOKA T
      PILOT-STUDY OF A RECOMBINANT HUMAN INTERLEUKIN-1-BETA IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/06/20 alle ore 00:10:31